Intrinsic Medicine and Phoenix Biotech Acquisition in Merger Agreement to Create Public Co Leveraging Human Milk Biology to Treat Gut-Brain Axis Disorders
Intrinsic Medicine and Phoenix Biotech Acquisition in Merger Agreement to Create Public Co Leveraging Human Milk Biology to Treat Gut-Brain Axis Disorders
內在醫學和Phoenix Biotech的合併協議中收購Phoenix Biotech，以創建利用母乳生物學治療腸腦軸疾病的上市公司
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間